scholarly journals Insulin Pump Best Practice Guide from the ABCD Diabetes Technology Network UK

2018 ◽  
Vol 18 (2) ◽  
pp. 69-70 ◽  
Author(s):  
Emma G Wilmot ◽  
Peter Hammond ◽  
Pratik Choudhary
Keyword(s):  
Health Care ◽  
Health Care Professionals ◽  
Professional Training ◽  
Best Practice ◽  
Insulin Pump ◽  
Insulin Pump Therapy ◽  
Pump Therapy ◽  
Practice Guide ◽  
Number Of Children ◽  
Diabetes Technology

The number of children and adults with Type 1 diabetes on insulin pump therapy in the UK continues to rise. However, there remains significant geographical variation in uptake. It is likely that health care professional training is a key factor driving this variation. In response, the Diabetes Technology Network UK has developed a national best practice guide to support health care professionals to develop and maintain their skills in insulin pump therapy. An overview of this guide is provided

Russian national guidelines on insulin pump therapy and continuous glucose monitoring for diabetes mellitus patients. DRAFT

2015 ◽  
Vol 61 (6) ◽  
pp. 55-78 ◽  
Author(s):  
Marina Vladimirovna Shestakova ◽  
Aleksandr Yuryevich Mayorov ◽  
Yury Ivanovich Philippov ◽  
Lyudmila Ibragimovna Ibragimova ◽  
Elena Vladimirovna Pekareva ◽  
...  
Keyword(s):  
Continuous Glucose Monitoring ◽  
Health Care Professionals ◽  
Clinical Guidelines ◽  
Insulin Pump ◽  
Glucose Monitoring ◽  
Insulin Pump Therapy ◽  
Diagnostic Tools ◽  
High Tech ◽  
Pump Therapy ◽  
Diabetes Patients

Insulin pump therapy (continuous subcutaneous insulin infusion, CSII) and continuous glucose monitoring (CGM) are high-tech treatment and diagnostic tools for diabetes patients management which are actively used worldwide. CSII initiation and pump-users supervision became a part of routine clinical practice in Russia along with the CGM. Present project of clinical guidelines is based on international and domestic experience in CSII and CGM for diabetes treatment. Guidelines should ensure uniformity of CGM and CSII usage in Russia by health care professionals and diabetes patients and provide them an international experience to guarantee height performance of the technology. This article contains a preliminary version of the guidelines (draft) prepared for further expert’s discussion and review. The final version of the clinical guidelines will be sent to the Ministry of Health of the Russian Federation for approval.

Initiation and Management of Insulin Pump Therapy

1993 ◽  
Vol 19 (1) ◽  
pp. 50-58 ◽  
Author(s):  
Suzanne M. Strowig
Keyword(s):  
Health Care ◽  
Health Care Provider ◽  
Care Provider ◽  
Insulin Pump ◽  
Infusion Pump ◽  
Blood Glucose Control ◽  
Insulin Delivery ◽  
Insulin Pump Therapy ◽  
Pump Therapy ◽  
Potential Risks

Insulin infusion pump therapy is a treatmertt option that facilitates achieving improved blood glucose control and lifestyle flexibility. These advantages are derived from the physiologic mode of insulin delivery and the pharmacologic advantages of using rapid-acting insulin. Patients who are sufficiently motivated and capable can learn to use the pump so that insulin adjustments can be made to compensate for changing circumstances. Although there are potential risks and side effects of using an insulin pump, these can be avoided through proper education and surveillance. The health care provider should be knowledgeable about the management of infusion pump therapy, including assessment of patient capabilities and practices, education, insulin adjustment, and techniques of use. The knowledge assists the health care provider in counseling patients to consider pump therapy and to manage patients already employing this mode of insulin delivery.

Automated Bolus Calculators and Connected Insulin Pens: A Smart Combination for Multiple Daily Injection Insulin Therapy

2021 ◽  
pp. 193229682110626
Author(s):  
David T Ahn
Keyword(s):  
Health Care Professionals ◽  
Insulin Pump ◽  
Insulin Pump Therapy ◽  
Daily Injection ◽  
Regulatory Oversight ◽  
Pump Therapy ◽  
Multiple Daily Injection ◽  
Insulin Pens ◽  
Bolus Insulin ◽  
Glycemic Outcomes

Although automated bolus calculators (ABCs) have become a mainstay in insulin pump therapy, they have not achieved similar levels of adoption by persons with diabetes (PWD) using multiple daily injections of insulin (MDI). Only a small number of blood glucose meters (BGMs) have incorporated ABC functionality and the proliferation of unregulated ABC smartphone apps raised safety concerns and eventually led to Food and Drug Administration (FDA)–mandated regulatory oversight for these types of apps. With the recent introduction of smartphone-connected insulin pens, manufacturer-supported companion ABC apps may offer an ideal solution for PWD and health care professionals that reduces errors of mental math when calculating bolus insulin dosing, increases the quality of diabetes data reporting, and improves glycemic outcomes.

scholarly journals The Future of Insulin Pump Therapy in India and Developing Countries Resale and Recycle – A New Vision

2019 ◽  
Vol 4 (3) ◽  
Keyword(s):  
Developing Countries ◽  
Insulin Pump ◽  
Insulin Pump Therapy ◽  
Insulin Pumps ◽  
Pump Therapy ◽  
Diabetes Technology ◽  
New Vision ◽  
The Many ◽  
Financial Recovery

Diabetes tsunami has hit India in a very devastating way in last decade. There is no doubt that CSII with Insulin pump Therapy has proved superior to MDI (multiple Dose Injection) therapy in Type1DM as well as Type2DM patients. Economics has been a very important issue while advocating the Pump to either patients, type 1 or type 2 Diabetes Mellitus patients. Out of 9 (Nine) patients using Insulin Pumps in our centre GANDHI CLINIC, PUNE, INDIA there are 5 Type 2 patients and 4 Type 1DM patients. Two Pumps are deposited at my Clinic due to the sad demise of the Type2DM patients. The relatives of these patients do wish to sell these pumps with some depreciation price i.e. at lower price than the new one. One patient (type2DM) has stopped using the Insulin pump due to the adverse advice from another healthcare provider who also wants to sell the pump at some discounted price. As per my survey in the Metro city of Pune (INDIA) approximately 700 insulin pumps are sold, out of these at least 5-7% of total pumps are not being used anymore. The unused pumps are at least 50 in number. Therefore revenue in terms of PUMPS in one region of INDIA is about 70000 US Dollars. Total number of pumps used in INDIA is 70000-72000 pumps approx. The total unused pumps by the patients could be about 3000 to 5000 pumps in total and thereby the revenue loss in this resource constrained country could be in millions of Dollars. This scenario is probably the same scene in many developing countries wherein the healthcare budgets are limited. In INDIA, Insulin Pump Therapy is not yet covered by Insurance policy of the patients. Since the pumps are usually purchased thru pocket expenses or with Loan or selling some assets like land or Gold, the relatives of the patients are not wrong in expecting some financial recovery after losing the most important thing i.e. the PERSON or even if patient does not want to continue the use of pump due to any reason. We do see refurbished cars sold and there are eligible and deserving candidates available who cannot purchase a new model of the Car. I am sure INDIA is an important market of Diabetes Technology related Products like Insulin Pump, similar to the many developing countries. This article is aimed at KOLs in Dialectology and Economists in the world for a basic policy change in favour of the patient care.

Heterogeneity of Access to Diabetes Technology Depending on Area Deprivation and Demographics Between 2016 and 2019 in Germany

2021 ◽  
pp. 193229682110286
Author(s):  
Marie Auzanneau ◽  
Joachim Rosenbauer ◽  
Werner Maier ◽  
Simone von Sengbusch ◽  
Johannes Hamann ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Pump ◽  
Regional Distribution ◽  
Migration Background ◽  
Insulin Pump Therapy ◽  
Federal State ◽  
Area Deprivation ◽  
Pump Therapy ◽  
Diabetes Technology

Background: Despite increasing use of technology in type 1 diabetes, persistent ethnic and socio-economic disparities have been reported. We analyzed how the use of insulin pump therapy and continuous glucose monitoring (CGM) evolved over the years in Germany depending on demographics and area deprivation. Method: We investigated the use of insulin pump and CGM between 2016 and 2019 in 37,798 patients with type 1 diabetes aged < 26 years from the German Prospective Follow-up Registry (DPV). Associations with federal state, area-deprivation quintile (German Index of Multiple Deprivation 2010 on district level), gender, and migration background were investigated over time using multiple logistic regression. Results: Between 2016 and 2019, the regional distribution of insulin pump use did not change substantially and the association with area deprivation remained non-linear and statistically non-significant. The effect of area deprivation on CGM use decreased continuously and disappeared in 2019 (OR [95%-CI] Q1 vs Q5: 1.85 [1.63-2.10] in 2016; 0.97 [0.88-1.08] in 2019). The effect of migration background on the use of either technology decreased over the years but remained significant in 2019. Girls had constantly higher odds of using an insulin pump than boys (OR: 1.25 [1.18-1.31] in 2019), whereas no gender difference was identified for CGM use. Conclusions: Although disparities decreased in Germany, access to diabetes technology still depends on migration background in 2019, and gender differences in pump use persist. As technological advances are made, further research is needed to understand the reasons for these persistent disparities.

The Use of Technology in Managing Diabetes in Youth Part 3–Special Considerations: Integration Into the School Setting

2020 ◽  
Vol 35 (5) ◽  
pp. 254-259
Author(s):  
Leah Wyckoff ◽  
Cari Berget
Keyword(s):  
Insulin Pump ◽  
School Setting ◽  
Glucose Monitoring ◽  
School Nurse ◽  
Insulin Pump Therapy ◽  
Pump Therapy ◽  
Healthcare Plan ◽  
Use Of Technology ◽  
Diabetes Technology ◽  
Diabetes In Youth

The advantages of continuous glucose monitoring (CGM) and insulin pump systems have increased the popularity of these devices among students in the school setting. The use of diabetes technology at school and school-sponsored activities strengthens the student’s consistent use of the technology and increases the overall beneficial effects. The school nurse has many considerations when supporting the student with diabetes technology. Integrating this technology into diabetes care at school can be complex with collaboration and safety considerations fundamental to success. This is the third article in a three-part series on the use of technology in managing diabetes in youth. The first article described CGM devices and provided tips for the school nurse in incorporating CGM into the student’s individualized healthcare plan. The second article summarized insulin pump technologies, from conventional insulin pump therapy to advance automated insulin delivery systems and described keys to success with insulin pump technologies. The purpose of this article is to address some special considerations for facilitating the use of diabetes technology in the school setting. Topics to be discussed are tips on including insulin pump therapy in the student’s individualized healthcare plan, safe use of diabetes technology during physical activity, and implications for school nursing practice.

Sign in / Sign up

Export Citation Format

Share Document